These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32989144)

  • 1. Driver mutations of the adenoma-carcinoma sequence govern the intestinal epithelial global translational capacity.
    Smit WL; Spaan CN; Johannes de Boer R; Ramesh P; Martins Garcia T; Meijer BJ; Vermeulen JLM; Lezzerini M; MacInnes AW; Koster J; Medema JP; van den Brink GR; Muncan V; Heijmans J
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25560-25570. PubMed ID: 32989144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The concerted action of oncogenic driver mutations directs global translation in intestinal epithelial cells.
    Smit W; Heijmans J
    Mol Cell Oncol; 2021; 8(4):1879614. PubMed ID: 34616863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
    Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
    Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells.
    Jossé L; Xie J; Proud CG; Smales CM
    Biochem J; 2016 Dec; 473(24):4651-4664. PubMed ID: 27760840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.
    Matano M; Date S; Shimokawa M; Takano A; Fujii M; Ohta Y; Watanabe T; Kanai T; Sato T
    Nat Med; 2015 Mar; 21(3):256-62. PubMed ID: 25706875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational repression of Ccl5 and Cxcl10 by 4E-BP1 and 4E-BP2 restrains the ability of mouse macrophages to induce migration of activated T cells.
    William M; Leroux LP; Chaparro V; Graber TE; Alain T; Jaramillo M
    Eur J Immunol; 2019 Aug; 49(8):1200-1212. PubMed ID: 31032899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
    Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
    J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential cancer mutations in cultured human intestinal stem cells.
    Drost J; van Jaarsveld RH; Ponsioen B; Zimberlin C; van Boxtel R; Buijs A; Sachs N; Overmeer RM; Offerhaus GJ; Begthel H; Korving J; van de Wetering M; Schwank G; Logtenberg M; Cuppen E; Snippert HJ; Medema JP; Kops GJ; Clevers H
    Nature; 2015 May; 521(7550):43-7. PubMed ID: 25924068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Mutation of
    Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
    Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translation initiation factor eIF2Bε promotes Wnt-mediated clonogenicity and global translation in intestinal epithelial cells.
    Smit WL; de Boer RJ; Meijer BJ; Spaan CN; van Roest M; Koelink PJ; Koster J; Dekker E; Abbink TEM; van der Knaap MS; van den Brink GR; Muncan V; Heijmans J
    Stem Cell Res; 2021 Aug; 55():102499. PubMed ID: 34399164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different mutation profiles associated to P53 accumulation in colorectal cancer.
    López I; P Oliveira L; Tucci P; Alvarez-Valín F; A Coudry R; Marín M
    Gene; 2012 May; 499(1):81-7. PubMed ID: 22373952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
    Molnár B; Galamb O; Péterfia B; Wichmann B; Csabai I; Bodor A; Kalmár A; Szigeti KA; Barták BK; Nagy ZB; Valcz G; Patai ÁV; Igaz P; Tulassay Z
    BMC Cancer; 2018 Jun; 18(1):695. PubMed ID: 29945573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTORC1 Inactivation Promotes Colitis-Induced Colorectal Cancer but Protects from APC Loss-Dependent Tumorigenesis.
    Brandt M; Grazioso TP; Fawal MA; Tummala KS; Torres-Ruiz R; Rodriguez-Perales S; Perna C; Djouder N
    Cell Metab; 2018 Jan; 27(1):118-135.e8. PubMed ID: 29275959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered miR-21, miRNA-148a Expression in Relation to KRAS Mutation Status as Indicator of Adenoma-Carcinoma Transitional Pattern in Colorectal Adenoma and Carcinoma Lesions.
    Igder S; Mohammadiasl J; Mokarram P
    Biochem Genet; 2019 Dec; 57(6):767-780. PubMed ID: 30997628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reappraisal to the study of 4E-BP1 as an mTOR substrate - A normative critique.
    Batool A; Aashaq S; Andrabi KI
    Eur J Cell Biol; 2017 Jun; 96(4):325-336. PubMed ID: 28427795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mTORC1/4E-BP/eIF4E Axis Promotes Antibody Class Switching in B Lymphocytes.
    Chiu H; Jackson LV; Oh KI; Mai A; Ronai ZA; Ruggero D; Fruman DA
    J Immunol; 2019 Jan; 202(2):579-590. PubMed ID: 30530594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eukaryotic initiation factor 4E is a novel effector of mTORC1 signaling pathway in cross talk with Mnk1.
    Batool A; Majeed ST; Aashaq S; Majeed R; Bhat NN; Andrabi KI
    Mol Cell Biochem; 2020 Feb; 465(1-2):13-26. PubMed ID: 31782083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRAS
    Charitou T; Srihari S; Lynn MA; Jarboui MA; Fasterius E; Moldovan M; Shirasawa S; Tsunoda T; Ueffing M; Xie J; Xin J; Wang X; Proud CG; Boldt K; Al-Khalili Szigyarto C; Kolch W; Lynn DJ
    Br J Cancer; 2019 Jul; 121(1):37-50. PubMed ID: 31133691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Coexpression of KITENIN and the ErbB4 CYT-2 Isoform Promotes the Transition from Colon Adenoma to Carcinoma Following APC loss.
    Bae JA; Kho DH; Sun EG; Ko YS; Yoon S; Lee KH; Ahn KY; Lee JH; Joo YE; Chung IJ; Lee SH; Kim H; Kim KK
    Clin Cancer Res; 2016 Mar; 22(5):1284-94. PubMed ID: 26527747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.